Kentaro Akiyama1,2, Eiji Warabi3, Kosuke Okada4, Toru Yanagawa5, Tetsuro Ishii3, Katsumi Kose6, Katsutoshi Tokushige7, Kazunori Ishige4, Yuji Mizokami4, Kenji Yamagata5, Kojiro Onizawa5, Shun-Ichi Ariizumi8, Masakazu Yamamoto8, Junichi Shoda9. 1. Doctoral Programs in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan. 2. Japan Society for the Promotion of Science, 5-3-1 Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan. 3. Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan. 4. Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan. 5. Division of Oral and Maxillofacial Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan. 6. Institute of Applied Physics, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8573, Japan. 7. Institute of Gastroenterology Internal Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. 8. Institute of Gastroenterology Surgery, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. 9. Medical Sciences, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.
Abstract
Nonalcoholic steatohepatitis (NASH) is one of the leading causes of chronic liver disease worldwide. However, details of pathogenetic mechanisms remain unknown. Deletion of both p62/Sqstm1 and Nrf2 genes spontaneously led to the development of NASH in mice fed a normal chow and was associated with liver tumorigenesis. The pathogenetic mechanism (s) underlying the NASH development was investigated in p62:Nrf2 double-knockout (DKO) mice. DKO mice showed massive hepatomegaly and steatohepatitis with fat accumulation and had hyperphagia-induced obesity coupled with insulin resistance and adipokine imbalance. They also showed dysbiosis associated with an increased proportion of gram-negative bacteria species and an increased lipopolysaccharide (LPS) level in feces. Intestinal permeability was elevated in association with both epithelial damage and decreased expression levels of tight junction protein zona occludens-1, and thereby LPS levels were increased in serum. For Kupffer cells, the foreign body phagocytic capacity was decreased in magnetic resonance imaging, and the proportion of M1 cells was increased in DKO mice. In vitro experiments showed that the inflammatory response was accelerated in the p62:Nrf2 double-deficient Kupffer cells when challenged with a low dose of LPS. Diet restriction improved the hepatic conditions of NASH in association with improved dysbiosis and decreased LPS levels. The results suggest that in DKO mice, activation of innate immunity by excessive LPS flux from the intestines, occurring both within and outside the liver, is central to the development of hepatic damage in the form of NASH.
Nonalcoholic steatohepatitis (NASH) is one of the leading causes of chronic liver disease worldwide. However, details of pathogenetic mechanisms remain unknown. Deletion of both p62/Sqstm1 and Nrf2 genes spontaneously led to the development of NASH in mice fed a normal chow and was associated with liver tumorigenesis. The pathogenetic mechanism (s) underlying the NASH development was investigated in p62:Nrf2 double-knockout (DKO) mice. DKO mice showed massive hepatomegaly and steatohepatitis with fat accumulation and had hyperphagia-induced obesity coupled with insulin resistance and adipokine imbalance. They also showed dysbiosis associated with an increased proportion of gram-negative bacteria species and an increased lipopolysaccharide (LPS) level in feces. Intestinal permeability was elevated in association with both epithelial damage and decreased expression levels of tight junction protein zona occludens-1, and thereby LPS levels were increased in serum. For Kupffer cells, the foreign body phagocytic capacity was decreased in magnetic resonance imaging, and the proportion of M1 cells was increased in DKO mice. In vitro experiments showed that the inflammatory response was accelerated in the p62:Nrf2 double-deficient Kupffer cells when challenged with a low dose of LPS. Diet restriction improved the hepatic conditions of NASH in association with improved dysbiosis and decreased LPS levels. The results suggest that in DKO mice, activation of innate immunity by excessive LPS flux from the intestines, occurring both within and outside the liver, is central to the development of hepatic damage in the form of NASH.
Nonalcoholic steatohepatitis (NASH) is a progressive liver disease characterized by
steatosis, inflammation, and fibrosis leading to liver cirrhosis and cancer [3]. NASH, a hepatic representation of metabolic syndrome,
is an increasingly common health problem globally [40].It is unlikely that the pathogenesis of NASH is dependent upon any single factor, and it is
likely that NASH is the result of multiple factors, including obesity/insulin
resistance-mediated steatosis, intestinal-derived lipopolysaccharides (LPS), oxidative
stress, lipotoxicity, and other conditions that promote inflammation, fibrosis, and
hepatocyte death [7, 38]. The molecular mechanisms corresponding to these pathogenic processes are
poorly understood.p62/A170/Sqstm1 is a cytoplasmic endosome-associated protein that acts as a scaffold for
atypical protein kinase C [17]. Recently, p62 was
reported to play an important role in selective autophagy of ubiquitin-binding protein
[24, 35].
p62-knockout (p62-KO) mice develop mature-onset obesity
after progressing to insulin and leptin resistance when fed a standard diet [33]. In a previous study, hyperphagia (overeating) was
reported to be the primary cause of obesity in p62-KO mice and was found to
be associated with a disruption in leptin signaling [12].Nuclear factor E2-related factor-2 (Nrf2), a transcription factor, is a master regulator of
the cellular adaptive response to oxidative stress [19, 23, 37]. Nrf2-knockout (Nrf2-KO) mice exhibit a
severe deficiency in the gene regulatory program for the antioxidant response, resulting in
high susceptibility to oxidative stress-related disorders and chemical carcinogenesis [20]. In a previous study, Nrf2-KO mice
were found to be prone to developing NASH/fatty liver disease when fed a diet deficient in
methionine and choline [32]. It is reported that
activation of Nrf2 prevents LPS-induced transcriptional upregulation of pro-inflammatory
cytokines, including interleukin (Il)-6 and IL-1β [22].Recent animal models of NASH include a diet-induced rat model developed by administration
of a methionine- and choline-deficient diet and hepatocyte-specific Pten-deficient mice
[15, 45].
However, these animal models show an unnatural decrease in body weight and rapid progression
of symptoms, and there is the possibility that they deviate from human NASH. The lack of
comparative animal models is a major reason for why the pathogenic mechanisms of NASH have
not been clarified, and the development of a novel model is required.In the current study, we developed a p62:Nrf2 gene
double-knockout (DKO) mouse by crossing a p62-KO mouse and an
Nrf2-KO mouse and investigated possible new mechanisms associated with
the deletion of both p62 and Nrf2 genes in the
pathogenesis of NASH. It is likely that p62 and Nrf2 deficiency plays a variety of
pathogenic roles in a number of organs and/or tissues that form a basis for NASH onset and
progression through a linkage between organs and tissues. We found that the DKO mouse is a
novel animal model of NASH.
Materials and Methods
Animal studies
All experiments were performed under protocols approved by the Institutional Animal Care
and Use Committees of the University of Tsukuba. Except where indicated in this paper or
cited in the respective references, animals were bred and maintained under standard
housing conditions with ad libitum access to food (MF: 5.1% fat, 23.1%
protein, 360 kcal/100 g; Oriental Yeast, Tokyo, Japan) and water. They were housed at an
ambient temperature of 20–23°C on a daily 12-h light/dark cycle with 30–70% relative
humidity and were weaned from their mothers between 3–4 weeks of age. All mice were kept
under specific pathogen-free conditions in an environmentally controlled clean room at the
Laboratory Animal Resource Center, University of Tsukuba.The mice used were 8-, 30-, and 50-week-old male wild-type (WT) C57BL/6J mice obtained
from Charles Laboratories Japan (Kanagawa, Japan) and bred in our own colony.
p62-KO and Nrf2-KO mice were generated and genotyped
as previously described [18, 24]. DKO mice were produced by crossing these mutant mice and
regenotyped. Before analysis, mice were crossed with C57BL/6J mice for>10 generations
to produce fertile offspring that grew normally. Male mice were used in all experiments.
In pair-feeding experiments, one 3-week-old DKO pup was weaned in a separate cage and
given a portion of standard diet (3.0 ± 0.1 g) per day until 25 weeks of age [12]. In probiotics experiments, DKO mice were
administered probiotics (VSL#3, VSL Pharmaceuticals, Gaithersburg, MD, USA) from 10 weeks
of age and observed at 25 weeks of age. VSL#3 was dissolved in drinking water (4.5 billion
colonies/ml).
Glucose tolerance test
Mice were fasted for 13 h before intraperitoneal injection of glucose (1 g/kg body
weight). A drop of blood drop was taken from the tail after 15, 30, 60, and 120 min. The
tail tip was cut 2 mm from the end, and the tail was pressed to collect a drop of blood at
the indicated time. Glucose levels were measured using a portable glucose meter (Ascensia,
Bayer HealthCare, Berlin, Germany).
Biochemical analyses
Serum glucose was detected using a glucose CII test kit (Wako, Tokyo, Japan). Serum
insulin was measured using a mouseinsulin ELISA kit (Morinaga, Kanagawa, Japan). Serum
leptin was measured using a mouse/ratleptin ELISA kit (Morinaga, Kanagawa, Japan).
Adiponectin was measured in serum using a MouseAdiponectin/Acrp30 Quantikine ELISA Kit
(R&D Systems, Minneapolis, MN, USA). The homeostatic model assessment for insulin
resistance (HOMA-IR) was determined by performing the following calculation:
HOMA-IR=fasting plasma insulin (mU/l) × fasting blood glucose (mg/dl)/405.
Histological analysis
Liver, intestine, and adipose tissues were fixed in 4% paraformaldehyde and embedded in
paraffin, and 2 µm-thick tissue sections were stained with
hematoxylin-eosin (H&E) and sirius red solution. For immunostaining of
4-hydroxy-2-nonenal (4-HNE), sections were stained using the indirect immunoperoxidase
method with anti-4HNE monoclonal antibodies (Ab) (JaiCA, Shizuoka, Japan). For
immunostaining of glutathione S-transferase P1, tissue sections were immunostained with
mAb (BML, Tokyo, Japan). To determine the histopathological lesions in nonalcoholic fatty
liver disease, the steatosis, activity, and fibrosis (SAF) score were assessed separately
for the grade of steatosis (from S0 to S3), the activity (from A0 to A4 by adding grades
of ballooning and lobular inflammation, both from 0 to 2), and the stage of fibrosis (from
F0 to F4) [2]. Histological changes in the
intestines were evaluated and graded by a blinded evaluator as follows: 0 (normal), no
damage; 1 (mild), slight submucosal and/or lamina propria separation; 2 (moderate),
moderate separation of the submucosa and/or lamina propria and/or edema in the submucosa
and muscular layers; 3 (severe), severe separation of the submucosa and/or lamina propria
and/or severe edema in the submucosa and muscular layers with regional villous sloughing;
and 4 (necrosis), loss of villi and necrosis [28].
LPS levels
Concentrations of LPS in plasma and feces were evaluated using a Pyrochrome limulus
amebocyte lysate assay (Associates of Cape Cod, East Falmouth, MA, USA). LPS levels are
expressed as Endotoxin Units (EU).
Fecal bacterial analysis
Stool samples were collected from mice, snap-frozen and stored at −80°C until use. DNA
extraction from fecal samples and analysis of the fecal microbiota using a 16S rDNA
library and terminal restriction fragment length polymorphisms were outsourced to
TechnoSuruga Laboratory Co., Ltd. (Shizuoka, Japan). Preparation of the fecal microbiota
using a 16S rRNA gene amplicon library and analysis of 16S rRNA gene amplicon sequencing
were outsourced to FASMAC Co., Ltd. (Kanagawa, Japan).
Magnetic resonance imaging (MRI) analyses
For analysis of Kupffer cells phagocytosis, MRI was performed using a 1T animal scanner
(MRTechnology, Ibaraki, Japan). Region-of-interest measurements of T2 values were
performed on consecutive pre- and superparamagnetic iron oxide (SPIO) administration.
Evaluation of microsphere phagocytosis
Prior to 5 min of liver perfusion, latex beads (1.0 µm diameter,
carboxylate-modified; FluoSpheres®, Thermo Fisher Scientific, Waltham, MA, USA) at 0.57
µl/g body weight were injected into the tail vein. Following liver
perfusion, cells were isolated. The Kupffer cell surface marker F4/80 was stained. The
percentage of phagocytic cells and the fluorescence intensity of latex beads in
F4/80-positive cells were evaluated by flow cytometry.
Flow cytometric analysis
Kupffer cells were stained with APC-conjugated anti-F4/80 Ab (Thermo Fisher Scientific,
Waltham, MA, USA), PerCP/Cy5.5 anti-mouseCD206 Ab (BioLegend, San Diego, CA, USA), PE
anti-mouseCD11c Ab (Biolegend, CA, USA), anti-macrophage receptor with collagenous
structure (MARCO) Ab (Bio-Rad, Hercules, CA, USA), and anti-class A macrophage scavenger
receptor (SR-A) Ab (R&D Systems, Minneapolis, MN, USA) with Alexa Fluor 488 (Thermo
Fisher Scientific, Waltham, MA, USA). Flow cytometry was performed using a Gallios flow
cytometer (Beckman Coulter, Brea, CA, USA).
Intestinal permeability assay
To evaluate epithelial permeability in the intestines, mice underwent gavage with
nondigestible 4 kDa fluorescein isothiocyanate (FITC)-dextran (Sigma-Aldrich, St. Louis,
MO, USA) at a dose of 0.5 mg/g body weight after fasting for 13 h. Serum (50
µl) was collected from the fundus at various time points (0, 1, 2, 3,
and 6 h), and the intensity of FITC in serum was measured using an iMark plate reader
(Bio-Rad, Hercules, CA, USA) with excitation at 488 nm. Data were plotted against the
standard curve of serial dilutions of FITC-dextran.
Immunoblot analysis
After extraction from mouse samples or cultured cells, each protein sample was subjected
to SDS/PAGE and transferred to a PVDF membrane (Bio-Rad, Hercules, CA, USA). Then the
corresponding primary and secondary antibodies were incubated to visualize the protein.
All antibodies used in this study are listed in Supplementary Table 1.
Total RNA was extracted from specimens or cultured cells, followed by cDNA synthesis.
qRT-PCR was performed with Fast SYBR Green Master Mix (Thermo Fisher Scientific, Waltham,
MA, USA). Data were normalized to the amount of Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) present in each sample and then averaged. Supplementary Table 2
provides a list of all the primers used in this study.
In vitro tissue culture studies and cell lines
Mouse primary Kupffer cells from 8- to 10-week-old male WT, Nrf2-KO,
p62-KO, and DKO mice were isolated via portal vein collagenase
treatment (Worthington Biochemical, Lakewood, NJ, USA) followed by centrifugation and cell
sorting. For Kupffer cell sorting, cells were incubated with APC-conjugated anti-F4/80 Abs
(Thermo Fisher Scientific, Waltham, MA, USA) for 30 min. Cells were sorted into
F4/80+ subpopulations using a Beckman Coulter MoFlo XDP cell sorter and
immediately processed for RNA isolation.The murine monocyte/macrophage cell line RAW264.7 was obtained from ATCC. The human colon
cancer cell line Caco-2 was purchased from RIKEN BRC (Ibaraki, Japan). Cells were cultured
at 37°C under 5% CO2 in high glucose Dulbecco’s modified Eagle’s medium
containing 4.5 g/l glucose, 1% penicillin-streptomycin, 10% fetal bovine serum, and 1%
nonessential amino acids (only in Caco-2).
Knockout of p62 and Nrf2 genes using the CRISPR-Cas9 system
The detailed instructions of a published protocol were followed to knock out p62 and Nrf2
genes using the CRISPR-Cas9 system [5]. Briefly, 20
bp target single-guide RNA sequences were obtained by screening p62 and
Nrf2 mRNA sequences using the CRISPR Design online software
(http://crispr.mit.edu/). After annealing, short double-strand DNA was ligated using the
BbsI digested pX330 plasmid. RAW264.7 and Caco-2 cells were transfected
with individual pX330 gDNA using the Neon Transfection System.
Measurement of transepithelial electrical resistance (TER)
Caco-2 cells were seeded into a polyethylene terephthalate membrane with 0.4
µm pores. The medium was changed every other day until complete
differentiation. Electrical resistance was measured using a Millicell-ERS electrical
resistance system (EMD Millipore, Billerica, MA, USA). TER values are expressed as
Ω·cm2. Measurements were performed on three replicates in three independent
experiments. In the LPS experiments, cell monolayers were treated with 100 EU /ml LPS for
3 or 6 h, and TER was measured.
Statistical analysis
Statistical analysis was conducted using IBM SPSS Statistics 22.0 (IBM, Armonk,, NY,
USA). Values are expressed as the mean ± SE. When two groups were compared, the unpaired
t-test was used for data analysis. Multiple-group comparisons were
performed using one-way analysis of variance (ANOVA). A P-value<0.05
was considered statistically significant.
Results
DKO mice fed a normal chow diet exhibited hyperphagia, obesity, insulin resistance,
and adipokine imbalance
DKO mice were negative for p62 and Nrf2 protein expression in the liver (Fig. 1A). The body weights of WT, Nrf2-KO, p62-KO, and
DKO mice fed a normal chow diet were monitored over a 42-week period in mice 8–50 weeks of
age. Mice lacking p62 and/or Nrf2 genes were viable and
had similar body weights at birth. Thereafter, p62-KO and DKO mice gained
weight much faster than WT and Nrf2-KO mice (Fig. 1B). At 30 weeks of age, the body weights for each genotype
were 37.8 ± 1.3 g for WT, 37.6 ± 1.0 g for Nrf2-KO, 49.7 ± 1.3 g for
p62-KO, and 46.5 ± 0.6 g for DKO. Liver mass was significantly
increased in DKO mice compared with in WT mice (Supplementary Fig. 1A) but was less than
that in p62-KO mice. Using computed tomography, percentages of body fat
and visceral fat weight were observed to increase in p62-KO and DKO mice
(Supplementary Fig. 1B). WT and Nrf2-KO mice showed only a slight
increase in food intake with age, with the average intake at 8 weeks being 3.0
g/day/mouse. In contrast, food intake of p62-KO and DKO mice increased
from 3.3 g/day/mouse at 8 weeks of age to 4.0 g/day/mouse at 30 weeks of age (Fig. 1C).
Fig. 1.
p62:Nrf2 gene double-knockout (DKO) mice fed a
normal chow diet exhibited hyperphagia, obesity, insulin resistance, and adipokine
imbalance. (A) Immunoblot analysis of Nrf2 and p62 in livers of wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO mice at 8
weeks of age. (B) Body weight changes in WT, Nrf2-KO,
p62-KO, and DKO mice (n=10–15 per group). (C) Food intake, (D)
fasting blood glucose concentration, fasting serum insulin concentration, and
homeostatic model assessment for insulin resistance (HOMA-IR) (n=8 per group) at 8
and 30 weeks of age. (E) Glucose tolerance tests were performed after mice were
fasted for 13 h at 8 and 30 weeks of age (n=7–9 per group). (F) Serum leptin and
adiponectin concentrations at 8 and 30 weeks of age (n=8 per group). Results are
presented as the mean ± SE. *P<0.05, significantly different
from the WT group; †P<0.05, significantly different
from the Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.
p62:Nrf2 gene double-knockout (DKO) mice fed a
normal chow diet exhibited hyperphagia, obesity, insulin resistance, and adipokine
imbalance. (A) Immunoblot analysis of Nrf2 and p62 in livers of wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO mice at 8
weeks of age. (B) Body weight changes in WT, Nrf2-KO,
p62-KO, and DKO mice (n=10–15 per group). (C) Food intake, (D)
fasting blood glucose concentration, fasting serum insulin concentration, and
homeostatic model assessment for insulin resistance (HOMA-IR) (n=8 per group) at 8
and 30 weeks of age. (E) Glucose tolerance tests were performed after mice were
fasted for 13 h at 8 and 30 weeks of age (n=7–9 per group). (F) Serum leptin and
adiponectin concentrations at 8 and 30 weeks of age (n=8 per group). Results are
presented as the mean ± SE. *P<0.05, significantly different
from the WT group; †P<0.05, significantly different
from the Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.In comparisons of blood biochemistry versus the WT mice, DKO mice showed the development
of hyperglycemia and a tendency towards increased fasting insulin levels and homeostatic
model assessment for insulin resistance (HOMA-IR). Of note, DKO mice exhibited insulin
resistance at 8 weeks of age (Fig. 1D). In
addition, DKO mice exhibited glucose intolerance in an intraperitoneal glucose tolerance
test (Fig. 1E). Serum leptin levels in
p62-KO and DKO mice increased significantly from 8 weeks to 30 weeks of
age compared with WT and Nrf2-KO mice. Serum adiponectin levels in
p62-KO and DKO mice decreased significantly (Fig. 1F).Collectively, the results indicated that DKO mice developed hyperphagia and obesity
(visceral fat accumulation) and exhibited insulin resistance and adipokine imbalance.
DKO mice fed a normal chow diet developed NASH and liver tumors
The time course of changes in liver histology for WT, Nrf2-KO,
p62-KO, and DKO mice are shown in Figs. 2A, 2B, and Supplementary Fig. 2A
p62-KO and DKO mice exhibited steatosis
at 30 weeks of age (Fig. 2C). DKO mice showed a
marked increase in infiltration of inflammatory cells in the liver compared with WT mice
(Fig. 2D). Hepatic fibrosis significantly
increased in DKO mice (Fig. 2E). In contrast, no
marked increase in hepatic fibrosis was observed in Nrf2-KO and
p62-KO mice (Fig. 2E). The
extent of fibrosis was confirmed by Masson’s trichrome staining and was closely associated
with hepatic fibrosis (Fig. 2F). While
steatosis, activity, and fibrosis (SAF) scores increased in Nrf2-KO and
p62-KO mice, scores showed greater increases in DKO mice (Fig. 2C-E). Immunostaining with 4-HNE was performed
to determine the presence of lipid peroxides. Increased staining was observed in the
livers of DKO mice at 30 weeks of age but not in Nrf2-KO and
p62-KO mice (Supplementary Fig. 2B).
Fig. 2.
p62:Nrf2 gene double-knockout (DKO) mice
developed nonalcoholic steatohepatitis and liver tumors. (A) Hematoxylin and eosin
(H&E)-stained sections of representative liver specimens from wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO mice at 8
and 30 weeks of age. Arrowheads indicate infiltration of inflammatory cells (scale
bar, 100 µm). (B) Sirius red-stained sections. (C–E) The steatosis,
activity, and fibrosis (SAF) scores for each group are shown (n=8 per group). (F)
Fibrotic areas in livers of WT, Nrf2-KO, p62-KO,
and DKO mice (n=8 per group). (G) Representative liver tumors in DKO mice.
Macroscopic view of tumors (upper panel), an H&E-stained section (middle panel;
T, tumor part; NT, non-tumor part), and a glutathione S-transferase P1-stained
section of the tumor (lower panel) (scale bar, 100 µm). The inset
areas show magnified views of part of the tumor in the middle panels (scale bar, 10
µm). Results are presented as the mean ± SE.
*P<0.05, significantly different from the WT group;
†P<0.05, significantly different from the
Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.
p62:Nrf2 gene double-knockout (DKO) mice
developed nonalcoholic steatohepatitis and liver tumors. (A) Hematoxylin and eosin
(H&E)-stained sections of representative liver specimens from wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO mice at 8
and 30 weeks of age. Arrowheads indicate infiltration of inflammatory cells (scale
bar, 100 µm). (B) Sirius red-stained sections. (C–E) The steatosis,
activity, and fibrosis (SAF) scores for each group are shown (n=8 per group). (F)
Fibrotic areas in livers of WT, Nrf2-KO, p62-KO,
and DKO mice (n=8 per group). (G) Representative liver tumors in DKO mice.
Macroscopic view of tumors (upper panel), an H&E-stained section (middle panel;
T, tumor part; NT, non-tumor part), and a glutathione S-transferase P1-stained
section of the tumor (lower panel) (scale bar, 100 µm). The inset
areas show magnified views of part of the tumor in the middle panels (scale bar, 10
µm). Results are presented as the mean ± SE.
*P<0.05, significantly different from the WT group;
†P<0.05, significantly different from the
Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.Tumor formation was observed in the livers of DKO mice. Macroscopic liver tumors were
observed in 12% (8/66) of DKO mice by 50 weeks of age (Fig. 2G). No tumors were observed in Nrf2-KO and
p62-KO mice. Microscopic findings revealed that tumors were comprised
of cellular masses with nuclear atypia, included lipid droplets in some cells, and were
partially surrounded by a fibrous cap. Intense glutathione S-transferase P1 staining was
observed in whole sections of tumors.With regard to visceral fat tissue, crown-like structures of inflammatory cells,
comprising macrophages surrounding dead or dying adipocytes (a histologic hallmark of the
pro-inflammatory process), were observed in p62-KO and DKO mice, with
greater inflammatory cell infiltration being observed in DKO mice (Supplementary Fig.
2C).Hepatic expression levels of tumor necrosis factor-α (Tnf-α),
IL-1β, IL-6, and toll-like receptor 4
(Tlr4) mRNA increased in DKO mice at 8 and 30 weeks of age compared
with WT mice. mRNA levels of transforming growth factor-β1 (Tgf-β1) and
procollagen-α1, both of which are closely associated with hepatic fibrosis, increased in
DKO mice at 30 weeks of age (Table
1). Visceral fat expression levels of IL-1β mRNA
significantly increased in DKO mice at 8 weeks of age. mRNA levels of
Tnf-α, IL-1β, Tlr4, monocyte
chemoattractant protein 1 (Mcp-1), CD14, and
Tgf-β1 increased in DKO mice at 30 weeks of age compared with WT mice
(Table 1).
Table 1.
Relative mRNA expression levels determined by qPCR for pathophysiological
factors in the liver and visceral fat tissue of mice at 8 and 30 weeks of
age
Age
8 weeks
30 weeks
Genes
WT
Nrf2-KO
p62-KO
DKO
WT
Nrf2-KO
p62-KO
DKO
Liver
Tnf-α
1.00 ± 0.10
1.11 ± 0.17
1.60 ± 0.07 a
3.09 ± 0.84 ab
2.47 ± 0.79
3.02 ± 0.70
4.25 ± 0.37 ab
5.43 ± 1.01 ab
IL-1β
1.00 ± 0.17
0.85 ± 0.08
2.69 ± 0.31 ab
3.52 ± 0.41 ab
1.68 ± 0.26
2.02 ± 0.15
3.19 ± 0.36 ab
4.18 ± 0.32 ab
IL-6
1.00 ± 0.25
1.27 ± 0.07
2.99 ± 0.32 ab
2.49 ± 0.28 ab
1.39 ± 0.57
0.97 ± 0.32
2.66 ± 0.77 ab
4.14 ± 0.96 ab
Tlr-4
1.00 ± 0.17
1.16 ± 0.06
1.09 ± 0.09
1.43 ± 0.12 abc
1.69 ± 0.23
1.82 ± 0.29
4.02 ± 0.35 ab
3.84 ± 0.43 ab
Tgf-β1
1.00 ± 0.15
1.07 ± 0.08
0.86 ± 0.05
1.35 ± 0.15
0.97 ± 0.71
0.98 ± 0.36
1.49 ± 0.61
1.82 ± 0.72 ab
Procollagen-α1
1.00 ± 0.16
1.26 ± 0.23
0.83 ± 0.13
1.24 ± 0.19
1.14 ± 0.73
1.30 ± 0.65
1.88 ± 0.39
2.27 ± 0.79 a
Visceral fat
Tnf-α
1.00 ± 0.10
1.17 ± 0.27
0.80 ± 0.10
1.30 ± 0.30
1.15 ± 0.26
1.23 ± 0.45
2.48 ± 0.22
5.72 ± 0.78 abc
IL-1β
1.00 ± 0.16
1.47 ± 0.61
1.60 ± 0.34
4.10 ± 0.86 abc
1.92 ± 0.52
6.92 ± 2.14
4.20 ± 1.22
32.26 ± 12.83 abc
Tlr-4
1.00 ± 0.06
0.93 ± 0.16
0.88 ± 0.11
0.81 ± 0.02
0.90 ± 0.08
0.98 ± 0.15
0.89 ± 0.08
1.66 ± 0.18 abc
Mcp-1
1.00 ± 0.11
2.26 ± 0.54
1.40 ± 0.20
1.75 ± 0.46
1.09 ± 0.12
1.31 ± 0.38
3.70 ± 1.11
15.55 ± 4.84 abc
Cd14
1.00 ± 0.18
0.64 ± 0.17
0.65 ± 0.13
0.48 ± 0.06
0.63 ± 0.04
0.70 ± 0.10
0.99 ± 0.27
3.29 ± 0.99 abc
Tgf-β1
1.00 ± 0.12
0.91 ± 0.13
0.85 ± 0.06
0.79 ± 0.07
0.65 ± 0.04
0.81 ± 0.14
0.82 ± 0.12
1.68 ± 0.15 abc
mRNA expression levels were normalized using the values of the WT group at 8 weeks
of age. Values are presented as the mean ± SE (n=8 per group).
aP<0.05, significantly different from the WT group;
bP<0.05, significantly different from the
Nrf2-KO group; cP<0.05,
significantly different from the p62-KO group. DKO,
p62:Nrf2 gene double-deficient mice; Tnf, tumor necrosis factor;
Tlr, toll-like receptor; Mcp, monocyte chemotactic protein; Cd, cluster of
differentiation; Tgf, transforming growth factor.
mRNA expression levels were normalized using the values of the WT group at 8 weeks
of age. Values are presented as the mean ± SE (n=8 per group).
aP<0.05, significantly different from the WT group;
bP<0.05, significantly different from the
Nrf2-KO group; cP<0.05,
significantly different from the p62-KO group. DKO,
p62:Nrf2 gene double-deficient mice; Tnf, tumor necrosis factor;
Tlr, toll-like receptor; Mcp, monocyte chemotactic protein; Cd, cluster of
differentiation; Tgf, transforming growth factor.These results suggested that DKO mice first developed liver inflammation at an early age
prior to obesity and then developed NASH and liver tumors with aging.
Modified microbiota composition and fecal LPS content in DKO mice
Fecal microbiota composition was determined in DKO mice at 30 weeks of age. Analysis was
conducted using culture-independent PCR amplification of the variable 4 region of
bacterial 16S rRNA genes followed by Illumina sequencing. Principal coordinates analysis
of the weighted UniFrac distance between samples revealed that the microbiota composition
was profoundly modified in DKO mice (Fig. 3A). Whereas gram-positive bacteria were the major representative signature
operational taxonomic unit accounting for the differences in intestinal microbiota
composition in WT mice, gram-negative bacteria were the predominant signature operational
taxonomic unit in p62-KO and DKO mice (Fig. 3B). The Porphyromonadaceae and
Paraprevotellaceae families were more abundant in DKO than in WT mice,
and the Lachnospiraceae and Ruminococcaceae families
were less abundant in DKO mice (Fig. 3C).
Fig. 3.
p62:Nrf2 gene double-knockout (DKO) mice showed a
modified microbiota composition and increased fecal lipopolysaccharide (LPS) levels.
(A) Principal coordinates analysis of the fecal microbiota from wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO mice at 30
weeks of age. (B) The relative abundance of gram-negative bacteria was calculated as
the percentage of bacteria relative to the total bacteria for fecal bacteria (n=8
per group). (C) The relative abundance of families of bacteria in feces was
examined. The relative abundance was calculated as the percentage of the bacterial
subgroup relative to the total bacteria. (D) Fecal LPS levels in mice (n=8 per
group). (E) Serum LPS levels in mice (n=8 per group). Results are presented as the
mean ± SE. *P<0.05, significantly different from the WT group;
†P<0.05, significantly different from the
Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.
p62:Nrf2 gene double-knockout (DKO) mice showed a
modified microbiota composition and increased fecal lipopolysaccharide (LPS) levels.
(A) Principal coordinates analysis of the fecal microbiota from wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO mice at 30
weeks of age. (B) The relative abundance of gram-negative bacteria was calculated as
the percentage of bacteria relative to the total bacteria for fecal bacteria (n=8
per group). (C) The relative abundance of families of bacteria in feces was
examined. The relative abundance was calculated as the percentage of the bacterial
subgroup relative to the total bacteria. (D) Fecal LPS levels in mice (n=8 per
group). (E) Serum LPS levels in mice (n=8 per group). Results are presented as the
mean ± SE. *P<0.05, significantly different from the WT group;
†P<0.05, significantly different from the
Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.LPS is the predominant cause of liver inflammation in NASH patients [4, 46].
Therefore, fecal and serum levels of LPS were determined in mice. Correlating with the
microbiota composition, fecal LPS concentrations were higher in p62-KO
and DKO mice than in WT mice (Fig. 3D), but
serum LPS concentrations were higher only in DKO mice (Fig. 3E).
Intestinal permeability increased in DKO mice
Previous studies have reported that increased intestinal permeability is observed more
frequently in NASH patients [30, 34]. In the current study, intestinal tissue sections
from WT, Nrf2-KO, p62-KO, and DKO mice were stained with
hematoxylin and eosin, and epithelial damage was scored according to the histology. There
was marked damage to intestinal epithelial morphology in DKO mice compared with WT mice.
At 30 weeks, damage scores increased in Nrf2-KO and
p62-KO mice, but they increased to a greater extent in DKO mice (Fig. 4A). Measurement of intestinal permeability by absorption of FITC-dextran showed
prominent enhancement in Nrf2-KO and DKO mice compared with WT at 8 weeks
of age. Permeability in DKO mice was further increased at 30 weeks of age (Fig. 4B).
Fig. 4.
Intestinal permeability increased in p62:Nrf2
gene double-knockout (DKO) mice. (A) Hematoxylin and eosin (H&E)-stained
sections of representative intestine specimens from wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO mice at 8
and 30 weeks of age (left panel) (scale bar, 100 µm). Histological
scores for intestinal epithelia (right panel) (n=8 per group). (B) Area under the
plasma concentration curve of fluorescein isothiocyanate (FITC)-dextran after
administration of the marker by gavage (n=8 per group). (C) Immunoblot analysis of
zona occludens-1 (Zo-1) in the intestines of WT, Nrf2-KO,
p62-KO, and DKO mice at 8 weeks of age and quantification of
immunoblotting of Zo-1 normalized to actin in mice (n=5 per group). (D) Immunoblot
analysis of Nrf2 and p62 in Caco-2 cells of WT, Nrf2-KO, and
p62-KO. (E) Barrier function was analyzed by transepithelial
electrical resistance (TER). Caco-2 cells were stimulated with 100 EU/ml
lipopolysaccharide (LPS) (EU, endotoxin units). TER was tested at different time
points (n=5 per group). (F) Quantification of immunoblotting of Zo-1, claudin 1, and
claudin 2 normalized to actin in Caco-2 cells (n=5 per group). Results are presented
as the mean ± SE. *P<0.05, significantly different from the WT
group; †P<0.05, significantly different from the
Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.
Intestinal permeability increased in p62:Nrf2
gene double-knockout (DKO) mice. (A) Hematoxylin and eosin (H&E)-stained
sections of representative intestine specimens from wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO mice at 8
and 30 weeks of age (left panel) (scale bar, 100 µm). Histological
scores for intestinal epithelia (right panel) (n=8 per group). (B) Area under the
plasma concentration curve of fluorescein isothiocyanate (FITC)-dextran after
administration of the marker by gavage (n=8 per group). (C) Immunoblot analysis of
zona occludens-1 (Zo-1) in the intestines of WT, Nrf2-KO,
p62-KO, and DKO mice at 8 weeks of age and quantification of
immunoblotting of Zo-1 normalized to actin in mice (n=5 per group). (D) Immunoblot
analysis of Nrf2 and p62 in Caco-2 cells of WT, Nrf2-KO, and
p62-KO. (E) Barrier function was analyzed by transepithelial
electrical resistance (TER). Caco-2 cells were stimulated with 100 EU/ml
lipopolysaccharide (LPS) (EU, endotoxin units). TER was tested at different time
points (n=5 per group). (F) Quantification of immunoblotting of Zo-1, claudin 1, and
claudin 2 normalized to actin in Caco-2 cells (n=5 per group). Results are presented
as the mean ± SE. *P<0.05, significantly different from the WT
group; †P<0.05, significantly different from the
Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.Intestinal permeability is regulated by tight junctions formed between intestinal
epithelial cells at most apical areas of the epithelium. Expression levels of the tight
junction protein zona occludens-1 (Zo-1) were evaluated by immunoblotting
of intestinal tissue lysates from DKO mice. Expression levels of Zo-1 decreased in the
intestines of Nrf2-KO and DKO mice compared with WT mice (Fig. 4C). Expression levels of Claudin 1 and Claudin
2 were not significantly different among the groups of mice (data not shown). mRNA
expression levels of intestinal Zo-1, Claudin 1, and
Claudin 2 were also not significantly different (Supplementary Fig.
3A).To investigate the effects of p62 or Nrf2 deficiency on
intestinal barrier function, an in vitro model in which Caco-2 epithelial
cells were grown in monolayers was constructed. Using the CRISPR-Cas9 system, Caco-2 cells
lacking the p62 or Nrf2 gene were also constructed.
Expression of p62 and Nrf2 protein in each gene-deficient cell was confirmed by
immunoblotting (Fig. 4D). TER is an indicator of
epithelial paracellular permeability to ionic solutes and was used to assess intestinal
barrier function. Compared with WT cells, TER was consistently decreased in
Nrf2-deficient cells (Fig.
4E). The results of immunoblotting showed that the expression of Zo-1 and Claudin 1
protein decreased in Nrf2-deficient cells compared with WT cells (Fig. 4F). Zo-1 mRNA expression
levels decreased in Nrf2-deficient cells. Claudin 1 mRNA
expression levels were not significantly different (Supplementary Fig. 3B).Because LPS causes intestinal barrier dysfunction, an in vitro model in
which Caco-2 epithelial cells were grown in monolayers was treated with LPS. Compared with
vehicle-treated cells, TER was consistently decreased in LPS-treated WT,
Nrf2-deficient, and p62-deficient cells at 3 h and 6
h, indicating disruption of the barrier function in the monolayers (Fig. 4E). Of note, Nrf2-deficient cells potently
inhibited the reduction in TER caused by treatment with LPS at all time points (Fig. 4E).
Changes in Kupffer cell phenotype in DKO mice
Macrophage polarization is a process by which macrophages express different functional
programs in response to microenvironmental signals [29]. In the livers of DKO mice at 8 weeks of age, M1 phenotype Kupffer cells but
not M2 phenotype Kupffer cells increased, as determined using flow cytometry for CD11c as
a marker for M1 macrophages and CD206 as a marker for M2 macrophages (Fig. 5A).
Fig. 5.
Change in Kupffer cell phenotype in p62:Nrf2 gene
double-knockout (DKO) mice. (A) CD11c and CD206 expression in F4/80+
cells (Kupffer cells) in the liver. Numbers in panels and quadrants are percentages
of the indicated populations. (B) Kupffer cell phagocytic function was determined by
superparamagnetic iron oxide (SPIO) magnetic resonance imaging (MRI). The SPIO
signal was calculated by MRI (reflecting the T2 value), and then the phagocytic
function was evaluated. (C) Phagocytic activity of F4/80+ cells in the
liver. Isolated liver F4/80+ cells were incubated with fluorescein
isothiocyanate (FITC) microspheres, and then FITC microsphere-positive cells were
analyzed. MARCO and SR-A expression in F4/80+ cells in the liver. (D)
Immunoblot analysis of Nrf2 and p62 in RAW264.7 cells of wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO. (E)
Immunoblot analysis of phosphorylated NF-kB p65 (p-NF-kB p65) and total NF-kB p65 in
RAW264.7 cells of WT, Nrf2-KO, p62-KO, and DKO and
quantification of immunoblotting of p-NF-kB p65 normalized to total NF-kB p65. Cells
were stimulated with 10 EU/ml lipopolysaccharide (LPS) (EU, endotoxin units).
Quantification of immunoblotting of p-NF-kB p65 normalized to total NF-kB p65. (F)
Relative mRNA expression levels of Tnf-α and IL-1β
mRNA in RAW264.7 cells (n=5 per group). mRNA expression levels were calculated as
the ratio relative to that in WT cells. Results are presented as the mean ± SE.
*P<0.05, significantly different from the WT group;
†P<0.05, significantly different from the
Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.
Change in Kupffer cell phenotype in p62:Nrf2 gene
double-knockout (DKO) mice. (A) CD11c and CD206 expression in F4/80+
cells (Kupffer cells) in the liver. Numbers in panels and quadrants are percentages
of the indicated populations. (B) Kupffer cell phagocytic function was determined by
superparamagnetic iron oxide (SPIO) magnetic resonance imaging (MRI). The SPIO
signal was calculated by MRI (reflecting the T2 value), and then the phagocytic
function was evaluated. (C) Phagocytic activity of F4/80+ cells in the
liver. Isolated liver F4/80+ cells were incubated with fluorescein
isothiocyanate (FITC) microspheres, and then FITC microsphere-positive cells were
analyzed. MARCO and SR-A expression in F4/80+ cells in the liver. (D)
Immunoblot analysis of Nrf2 and p62 in RAW264.7 cells of wild-type (WT),
Nrf2-knockout (KO), p62-KO, and DKO. (E)
Immunoblot analysis of phosphorylated NF-kB p65 (p-NF-kB p65) and total NF-kB p65 in
RAW264.7 cells of WT, Nrf2-KO, p62-KO, and DKO and
quantification of immunoblotting of p-NF-kB p65 normalized to total NF-kB p65. Cells
were stimulated with 10 EU/ml lipopolysaccharide (LPS) (EU, endotoxin units).
Quantification of immunoblotting of p-NF-kB p65 normalized to total NF-kB p65. (F)
Relative mRNA expression levels of Tnf-α and IL-1β
mRNA in RAW264.7 cells (n=5 per group). mRNA expression levels were calculated as
the ratio relative to that in WT cells. Results are presented as the mean ± SE.
*P<0.05, significantly different from the WT group;
†P<0.05, significantly different from the
Nrf2-KO group; §P<0.05,
significantly different from the p62-KO group.LPS polarizes macrophages towards the M1 phenotype. M1 macrophages are implicated in the
initiation and maintenance of inflammation. To directly test the inflammatory response of
Kupffer cells, Kupffer cells from WT, Nrf2-KO, p62-KO,
and DKO mice at 8 weeks of age were isolated and stimulated with LPS ex
vivo. Analysis using qRT-PCR revealed that upregulation of
Tnf-α mRNA with vehicle treatment was only present in DKO mice,
indicating innate immunity activation at an early age, and that the magnitude of the
upregulation was further potentiated by LPS treatment (data not shown). There was no
significant difference in the number of F4/80-positive cells, which is a surface marker of
Kupffer cells (Supplementary Fig. 4).Impairment of the phagocytic function of Kupffer cells may play a critical role in the
development of NASH [39, 44]. Therefore, the effects in the liver parenchymal phase were
determined by SPIO-MRI, and Kupffer cell phagocytic activity was assessed in mice. The
magnitude of changes in the T2 value of the liver parenchymal phase, which reflects the
Kupffer cell phagocytic status of SPIO, was smaller in Nrf2-KO,
p62-KO, and DKO mice than in WT mice (Fig. 5B). Simply put, the phagocytic ability decreased in these
mice. When the ability of F4/80-positive cells to uptake latex beads was investigated by
flow cytometry, the bead phagocytic ability was lower in Nrf2-KO and DKO
mice than in WT and p62-KO mice (Fig.
5C). Correlating with these findings, the positive fraction of MARCO, a scavenger
receptor, decreased in Nrf2-KO and DKO mice. There was no significant
difference observed for the positive fraction of SR-A (Fig. 5C).As noted, macrophages polarizing towards the M1 phenotype and innate immunity were
activated in the livers of DKO mice at 8 weeks of age. The findings suggest that the
Kupffer cells of DKO mice due to their genetic background accelerate the inflammatory
response to excessive LPS flux through an increase in the susceptibility of innate
immunity to LPS. We produced RAW264.7 lacking the p62 or
Nrf2 gene using the CRISPR-Cas9 system. In vitro
experiments were conducted to evaluate the inflammatory response to LPS. Expression of p62
and Nrf2 protein in each gene-deficient cell was confirmed by immunoblot analysis (Fig. 5D). Analysis showed that phosphorylation of
Nuclear factor-kappa B p65 (NF-κB p65) increased in Nrf2-deficient cells
compared with WT cells (Fig. 5E). Interestingly,
Tnf-α and IL-1β mRNA expression levels following
treatment with low-dose LPS were also upregulated in Nrf2-deficient cells
compared with WT cells (Fig. 5F).
Diet restriction improved NASH in DKO mice
To confirm the association between hyperphagia-induced obesity and NASH development in
DKO mice, diet restriction by pair-feeding was conducted using DKO mice. Pair-feeding
restricted the intake of standard chow to 3.0 ± 0.1 g/day/mouse. DKO mice subjected to
diet restriction showed a body weight gain curve similar to WT mice fed ad
libitum (Fig. 6A). When compared with ad libitum DKO mice with liver steatosis,
inflammation, and fibrosis, pair-feed DKO mice showed dramatic improvements in these
pathological conditions in the liver (Figs. 6B
and C). Improvements in NASH conditions were coupled with recovered intestinal
permeability (Fig. 6D) and improved microbiota
composition (e.g., a decreased proportion of gram-negative bacteria and decreased fecal
LPS concentrations) (Fig. 6E) and thereby
decreased serum LPS concentrations (Fig.
6F).
Fig. 6.
Diet restriction improved nonalcoholic steatohepatitis (NASH) in
p62:Nrf2 gene double-knockout (DKO) mice. (A)
Body weight changes in wild-type (WT), ad libitum DKO, and
pair-feeding mice (n=10–15 per group). (B) Hematoxylin and eosin (H&E)- and
sirius red-stained sections of representative liver specimens from the ad
libitum DKO and pair-feeding groups at 30 weeks of age (scale bar, 100
µm). (C) The steatosis, activity, and fibrosis (SAF) scores for
each group are shown (8 per group). (D) Area under the plasma concentration curve of
fluorescein isothiocyanate (FITC)-dextran in plasma after administration of the
marker by gavage (n=8 per group). (E) The relative abundance of gram-negative
bacteria was calculated as the percentage of bacteria relative to the total bacteria
for fecal bacteria (n=8 per group). (F) Fecal and serum lipopolysaccharide (LPS)
levels in WT, ad libitum DKO, and pair-feeding mice (n=8 per
group). Results are presented as the mean ± SE. *P<0.05,
significantly different from the ad libitum DKO group.
Diet restriction improved nonalcoholic steatohepatitis (NASH) in
p62:Nrf2 gene double-knockout (DKO) mice. (A)
Body weight changes in wild-type (WT), ad libitum DKO, and
pair-feeding mice (n=10–15 per group). (B) Hematoxylin and eosin (H&E)- and
sirius red-stained sections of representative liver specimens from the ad
libitum DKO and pair-feeding groups at 30 weeks of age (scale bar, 100
µm). (C) The steatosis, activity, and fibrosis (SAF) scores for
each group are shown (8 per group). (D) Area under the plasma concentration curve of
fluorescein isothiocyanate (FITC)-dextran in plasma after administration of the
marker by gavage (n=8 per group). (E) The relative abundance of gram-negative
bacteria was calculated as the percentage of bacteria relative to the total bacteria
for fecal bacteria (n=8 per group). (F) Fecal and serum lipopolysaccharide (LPS)
levels in WT, ad libitum DKO, and pair-feeding mice (n=8 per
group). Results are presented as the mean ± SE. *P<0.05,
significantly different from the ad libitum DKO group.
Discussion
The major findings of this study are that p62 deficiency resulted in
hyperphagia-induced obesity coupled with insulin resistance and adipokine imbalance as well
as dysbiosis and that Nrf2 deficiency resulted in intestinal barrier
dysfunction and an accelerated inflammatory response to LPS in Kupffer cells. Both defects
resulted in the onset and progression of NASH and were associated with hepatic tumorigenesis
in DKO mice fed a normal diet. However, p62 or Nrf2 single
gene-knockout mice did not progress to NASH.Of note, in DKO mice, a high-fat diet is not needed for the development of NASH. In this
regard, inflammatory events may lead to fat accumulation (steatosis) in the livers [26]. As proposed by the multiple parallel hits theory,
which is currently accepted as the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
[38], inflammatory mediators from the intestines
(e.g., LPS) and adipose tissue (e.g., adipokines) could play a central role in the cascade
of hepatic inflammation and fibrosis development. It is possible that, in DKO mice,
activation of innate immunity by an excessive LPS flux, occurring both within and outside
the liver, is a central pathway that regulates the development of hepatic damage in the form
of NASH.Cumulative data suggests that dysbiosis of the intestinal microbiota is associated with the
onset and progression of NASH [9]. Several studies
have reported that serum LPS levels are elevated in NAFLD patients compared with controls
[14, 25].
The fecal microbiota in NAFLD or NASH patients has been assessed using culture-independent
techniques such as sequencing of a conserved region in the bacterial 16S rRNA gene.
Microbiota samples from patients with NAFLD or NASH have a higher proportion of members of
the Porphyromonadaceae family and a lower proportion of members of the
Lachnospiraceae and Ruminococcaceae families than those
from healthy people [42, 47]. Flora analysis of DKO mice in the current study showed an increased
proportion of Porphyromonadaceae and decreased proportions of
Lachnospiraceae and Ruminococcaceae (Fig. 3). Because we compared proportions of
microflora, it is impossible to accurately compare the number of bacteria. The fecal LPS
concentration was elevated in both p62-KO and DKO mice. However, serum LPS
concentrations were elevated only in DKO mice. Interestingly, diet restriction by
pair-feeding decreased fecal and serum LPS concentrations in DKO mice, which in turns
resulted in an improvement in the hepatic conditions of NASH (Fig. 6). Moreover, administration of the probiotic VSL#3 from 10 to
25 weeks of age increased the bacterial species Bifidobacterium infantis
and Streptococcus thermophilus in feces and reduced serum LPS
concentrations (Supplemental Figs. 5A and 5B). In addition, steatosis, inflammation, and
fibrosis were improved in the liver (Supplemental Fig. 5C). From these results, it is
suggested that p62 deficiency in DKO mice modifies the intestinal flora
(e.g., increasing the proportion of gram-negative bacteria) through hyperphagia and thereby
increases fecal LPS concentrations. In addition, the activation of TLR4 by LPS from
intestinal Gram-negative bacteria has recently been shown to promote the development of
hepatocellular carcinoma [6]. Therefore, it is likely
that in DKO miceLPS is closely involved in the liver tumorigenesis, since the expression
levels of genes downstream of TLR4 were increased in the liver (Table 1).Previous studies suggest a pathological link between intestinal permeability status and
NASH. It is reported that the intestinal microbiome is perturbed in both people with obesity
and NAFLD patients, which in turn may lead to increased fecal LPS levels and result in leaky
gut [41]. Luca et al. reported that
intestinal permeability is increased in patients with NAFLD and that the staining intensity
of Zo-1 in the intestinal epithelia significantly decreases in patients with NAFLD [30]. The results of the current study (Fig. 4) indicate that both Nrf2
deficiency in mice and Nrf2 deletion in Caco-2 cells contribute to
increased intestinal permeability through a decrease in Zo-1 expression levels, suggesting
that Nrf2 is closely involved in the maintenance of intestinal barrier function. In
addition, Nrf2 is known to inhibit the expression levels of i-nitric oxide synthase [27]. Therefore, in the damaged intestines of DKO mice
(Fig. 4), an LPS-induced increase in inducible
NO synthase activity may also be an important factor responsible for the increased
permeability as reported previously [11].Obesity is an inflammatory condition characterized by increased activity of the innate
immune system. Increased sensitivity of the liver to LPS in people with obesity is closely
associated with the pathogenesis of NASH [43].
Understanding the role of Kupffer cells in the context of inflammation in the pathogenetic
process of LPS-induced liver injury has recently increased. Imajo et al.
demonstrated that obesity-associated increases in leptin levels result in an increased
sensitivity of Kupffer cells to low doses of LPS through increased expression of CD14, a
receptor for LPS and LPS-binding protein complexes [16]. In the current study, increased leptin levels in DKO mice at 8 and 30 weeks
of age were associated with increased expression levels of pro-inflammatory cytokines in the
liver at 8 and 30 weeks of age and those in visceral fat at 30 weeks of age (Table 1).Activation of innate immunity may play a role in the pathophysiology of
inflammation-induced liver damage. Kupffer cells play an important role in innate immunity.
Macrophages (Kupffer cells) undergo specific differentiation depending on the local tissue
environment, responding to environmental cues within tissues such as damaged cells or
microbial products to differentiate into distinct functional phenotypes. In the current
study, phenotypic changes in Kupffer cells were observed in DKO mice (Fig. 5), with the proportion of M1 phenotype Kupffer cells
increasing. The M1 macrophage phenotype, which is characterized by the production of high
levels of pro-inflammatory cytokines and high production of reactive nitrogen and oxygen
intermediates, is implicated in initiation and maintenance of inflammation. Therefore, the
phenotypic changes are thought to worsen the hepatic conditions of NASH [1].The responsiveness of cultured macrophages to low doses of LPS increased with
Nrf2 deletion in the current study (Fig. 5). Activation of Nrf2 prevents LPS-induced upregulation of pro-inflammatory
cytokines [22]. Therefore, an increased inflammatory
response to low doses of LPS in Nrf2 deficiency and hyperleptinemia in
p62 deficiency are closely associated with maintenance of inflammation in
the livers of DKO mice.In this study, the phagocytic ability of Kupffer cells decreased in DKO mice. Flow
cytometry revealed that Nrf2 deficiency reduced the expression level of
MARCO as a scavenger receptor and decreased the phagocytic ability of Kupffer cells (Fig. 5). In humans and rats, impaired phagocytic
functions of Kupffer cells are causatively associated with the development of NASH [39]. MARCO restricts TLR4 responses to LPS, and
expression levels of MARCO increase when LPS is administered [31]. Therefore, decreased expression of MARCO in DKO mice may increase
the TLR4 response to low doses of LPS.Several studies have reported the involvement of p62 and NRF2 in human NASH. p62 is a
component of Mallory-Denk bodies, which are protein aggregates that accumulate in damaged
liver cells in NASH, cirrhosis, and HCC [36].
Impaired autophagic flux is associated with increased endoplasmic reticulum stress during
the development of NASH, and consequently, levels of hepatic p62 protein are significantly
increased in patients with NASH compared with those in control subjects [10]. In contrast, Duran et al. showed
that p62 expression was significantly lower in tumoral hepatic stellate cells, causing
impaired repression of fibrosis and inflammation [8].
Activation of NRF2 is also observed in human NASH [13, 21], indicating that NRF2 plays an
important role in adaptation to oxidative stress in NASH and tumors. These reports indicate
that p62 and NRF2 may have important roles in human NASH progression.In conclusion, feeding of a standard diet to DKO mice resulted in the development of NASH
and was associated with tumorigenesis. In vivo and in
vitro studies revealed that p62 deficiency resulted in
hyperphagia-induced obesity coupled with insulin resistance and adipokine imbalance as well
as dysbiosis (e.g., an increased proportion of gram-negative bacteria) and that
Nrf2 deficiency resulted in intestinal barrier dysfunction and an
accelerated inflammatory response to LPS in Kupffer cells. In mice, activation of innate
immunity by excessive LPS flux, occurring both within and outside the liver (e.g.,
intestines and visceral adipose tissue), is central to the development of hepatic damage in
the form of NASH (Fig. 7). Because of the phenotypic similarities to the clinical features of human NASH,
e.g., obesity (visceral fat accumulation) coupled with metabolic syndrome, insulin
resistance, and adipokine imbalance, DKO mice represent a unique animal model for
investigating the pathogenesis of human NASH and exploring novel targets for the prevention
and/or treatment of NASH. A therapeutic approach targeting the intestinal flora and
intestinal barrier function with probiotics may be useful for the potential management of
NASH.
Fig. 7.
Summary of nonalcoholic steatohepatitis in p62:Nrf2 double-knockout
(DKO) mice.
Summary of nonalcoholic steatohepatitis in p62:Nrf2 double-knockout
(DKO) mice.
Author Contributions
K.A., E.W., K.O., and J.S. developed the study concept and experimental design. K.A.
performed all animal study procedures and most in vitro experiments. K.T. scored mouse
livers for the features of NASH. T.Y., T.I., and K.K. helped with the design and
interpreting the results. K.A., E.W., K.O., and J.S. interpreted the data and wrote the
manuscript.
Conflict of Interest
The authors declare that they have no potential conflicts of interest.
Authors: K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima Journal: Biochem Biophys Res Commun Date: 1997-07-18 Impact factor: 3.575
Authors: Alison L Harte; Nancy F da Silva; Steven J Creely; Kirsty C McGee; Thomas Billyard; Elham M Youssef-Elabd; Gyanendra Tripathi; Esmat Ashour; Mohga S Abdalla; Hayat M Sharada; Ashraf I Amin; Alastair D Burt; Sudhesh Kumar; Christopher P Day; Philip G McTernan Journal: J Inflamm (Lond) Date: 2010-03-30 Impact factor: 4.981
Authors: Sheldon Rowan; Shuhong Jiang; Min-Lee Chang; Jonathan Volkin; Christa Cassalman; Kelsey M Smith; Matthew D Streeter; David A Spiegel; Carlos Moreira-Neto; Naila Rabbani; Paul J Thornalley; Donald E Smith; Nadia K Waheed; Allen Taylor Journal: Free Radic Biol Med Date: 2020-02-14 Impact factor: 7.376
Authors: Tanyara B Payolla; Caio J Teixeira; Fabio T Sato; Gilson M Murata; Gizela A Zonta; Frhancielly S Sodré; Carolina V Campos; Filiphe N Mesquita; Gabriel F Anhê; Silvana Bordin Journal: Nutrients Date: 2019-09-05 Impact factor: 5.717